Menu
Portfolio Oversight

Independent oversight and assurance of claims portfolios.

Maintain a clearer view of portfolio progress, operational delivery and emerging exceptions. Insyte IQ combines recurring management information, file sampling and operational review within an agreed oversight mandate.

Evidence in context

Connect reported progress with underlying evidence.

Portfolio data provides the starting point. Targeted review helps establish where reporting is supported, where information is incomplete and which matters require further investigation.

Review framework
01
Portfolio information

Understand reported status and changes over the agreed period.

02
Supporting evidence

Connect selected files and operational records to the review questions.

03
Exceptions and follow up

Report open matters, evidence gaps and agreed actions.

Illustrative review framework

A mandate shaped around your portfolio

Agree review coverage, reporting frequency, access and escalation thresholds at the outset. Recurring MI reviews, file sampling, operational follow up and site audits can form part of the scope.

Attention where it is needed

Use a defined review at a point of change, or establish ongoing oversight across a funding relationship. Findings help focus attention on inconsistencies and matters requiring investigation.

What the review provides

Clear findings. Defined next steps.

Outputs are shaped around the questions, scope and reporting arrangements agreed for the engagement.

  • Portfolio oversight reporting
  • Exception register with evidence references
  • Agreed actions, ownership and target dates
  • Follow up reporting on unresolved matters

Review coverage, sampling and reporting frequency are agreed for each engagement. Findings reflect the scope, period and evidence reviewed.

A connected view of the portfolio.

Bring assurance, ongoing oversight, data intelligence and settlement review together around your mandate.

Start a conversation

Discuss your portfolio.

Tell us what you need to understand. We can discuss the scope, evidence and reporting your portfolio requires.